USPTO trademark

RELYSTEN

Opposition periodUSPTOWord markClass 5

"RELYSTEN" is a word mark owned by Beam Therapeutics Inc., filed at the USPTO on March 27, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Beam Therapeutics Inc. portfolioGet this data via the API
Official USPTO record
RELYSTEN trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 9, 2026
Filed
March 27, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99729369
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns RELYSTEN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Beam Therapeutics Inc.

BEAM · Cambridge, United States

10 trademarks in the portfolioView company

Representative

John V. Hobgood, Esquire

Wilmer Cutler Pickering Hale and Dorr LLP

Goods and services

What the mark covers

The products and services RELYSTEN is filed for, grouped by Nice class.

  • Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Sickle Cell Disease

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Extension of time to oppose received
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Assigned to examiner
  7. Application filing receipt mailed
  8. New application office supplied data entered
  9. New application entered
FAQ

About RELYSTEN

Who owns the trademark "RELYSTEN"?

The USPTO trademark "RELYSTEN" (application 99729369) is owned by Beam Therapeutics Inc.

What is the status of "RELYSTEN"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RELYSTEN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3f3b-cc8b-70e6-bc07-2ba581f72e83
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3f3b-cc8b-70e6-bc07-2ba581f72e83",
  "object": "trademark",
  "mark_text": "RELYSTEN",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99729369",
  "filing_date": "2026-03-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Beam Therapeutics Inc.",
      "entity_id": "ent_019eb715-f50c-77e9-863d-7dcc7353cc9a"
    }
  ]
}